Old heart drug takes on superbugs in cancer patients
NCT ID NCT07505446
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This lab study looks at whether verapamil, a common blood pressure medicine, can make antibiotics work better against drug-resistant bacteria. Researchers will test bacteria samples from 100 cancer patients in Egypt. The goal is to find a cheap, new way to fight superbugs, but this is early lab research, not a treatment for patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANTIBIOTIC RESISTANCE are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new antibiotic combo beat Drug-Resistant urinary infections in the blood?
- Superbug sleuths decode the DNA of drug-resistant e. coli to stop its spread
- New 6-Month TB drug cocktail could replace Year-Long ordeal
- Gut check: hospital study tracks superbug carriers to predict infections
- New tool could spot tough pneumonia early
- New antibiotic combo tested against superbugs in hospitals